Given that we have previously identified differential expression of heterogeneous nuclear ribonucleoprotein K (HNRNPK) as being prognostic in AML,26, 27 we sought to validate its differential expression by performing immunohistochemistry analysis. The gene discussed is HNRNPK; the disease is acute myeloid leukemia.